Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
1. To evaluate the efficacy of TNF‐alpha antibody for induction of remission in ulcerative colitis.
2. To determine adverse events associated with TNF‐alpha antibody treatment in ulcerative colitis.